GlassScriptPhysician profile
Pompilio Perez
NPI 1558497909
$1,144.60
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $467 · 2023: $299 · 2024: $44.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.42 | 2021-2024 | |
| Baxter Healthcare | $78.62 | 2022 | |
| Mylan Specialty L.P. | $65.15 | 2021-2023 | Yupelri |
| Welch Allyn | $63.33 | 2021 | |
| Vanda Pharmaceuticals INC. | $59.63 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $59.15 | 2022-2023 | Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $57.84 | 2021-2022 | |
| Insulet Corporation | $49.92 | 2022-2023 | Omnipod |
| Alkermes, INC. | $34.48 | 2023 | Lybalvi, Aristada |
| Merck Sharp & Dohme LLC | $30.05 | 2023 | Belsomra, Steglatro, Steglujan |
| Amgen INC. | $28.32 | 2022 | |
| Exact Sciences Corporation | $24.77 | 2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $16.51 | 2021 | |
| Novo Nordisk INC | $13.51 | 2021 | |
| Dexcom, INC. | $12.86 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pompilio Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.